Morningside
Morningside is a venture capital firm based in the greater Boston area, specializing in investments in companies that focus on innovative science and technology. Established in 1986 as a family office for the Chan family, Morningside emphasizes a long-term approach to company-building and maintains a strong commitment to ethical practices. The firm is staffed by a team of experienced investment professionals with expertise in various sectors, including life sciences, digital health, artificial intelligence, materials, and technology. In addition to its investment activities, Morningside is dedicated to philanthropic efforts, supporting education, research, and healthcare initiatives such as the Harvard T.H. Chan School of Public Health, UMass Chan Medical School, and the MIT Morningside Academy for Design.
Almond Fintech
Seed Round in 2021
Almond Fintech, based in Boston and Singapore, operates a blockchain-based funds transfer infrastructure that connects numerous financial institutions worldwide. The company focuses on facilitating cross-border payments and remittances, allowing millions of users to send money globally through their existing financial services. Almond Fintech offers a suite of APIs that support peer-to-peer transfers and digital currency-based international settlements. Additionally, it provides a customizable web and mobile user interface that enhances accessibility and user experience. By promoting interoperability between various mobile wallets and services, Almond Fintech aims to streamline currency exchange and payment processes for individuals and businesses alike.
DeepCure Inc. specializes in drug discovery services powered by artificial intelligence. The company employs advanced algorithms for De-novo Lead Discovery, which analyzes drug candidates from a virtual library, and utilizes AI-driven Lead Optimization to enhance drug development processes. Additionally, DeepCure's proprietary database, MoIDB, is designed to maximize the scale, diversity, and synthesizability of the chemical search space. Founded in 2018 and based in Boston, Massachusetts, DeepCure aims to accelerate the development of innovative, first-in-class precision therapeutics that address unmet medical needs. The company combines deep learning algorithms with cloud computing to improve pre-clinical drug development, ultimately assisting scientists and healthcare professionals in creating more effective therapeutic molecules for various disease targets.
Catalant
Venture Round in 2021
Catalant is a Boston-based software company that specializes in strategy execution solutions for global enterprises. Founded in 2013, the company's platform enables businesses to break down strategic objectives, access and deploy resources, collaborate on execution, measure value, and continuously improve processes. Catalant's network comprises over 65,000 experts and 1,000 firms, serving more than 30% of the Fortune 100.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.